New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
11:22 EDTIDXXIDEXX says FTC grants final approval of consent agreement
IDEXX Laboratories announced that the Commissioners of the U.S. Federal Trade Commission have granted final approval of the consent agreement previously reached between the company and the staff of the FTC Bureau of Competition. The Commission had preliminarily approved the consent agreement in December 2012 and placed the agreement and a proposed draft complaint on public record for comment.The company said, "While we admit no wrongdoing and continue to believe that our distribution practices did not violate the antitrust laws, this marks final resolution of the multi-year FTC investigation."
News For IDXX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
07:55 EDTIDXXZoetis could make a bid for IDEXX, says Canaccord
Canaccord hosted investor meetings with IDEXX (IDXX) management, who spoke about new product launches and their market share in light of competitive concerns. Management declined to comment on Zoetis' (ZTS) potential interest in scaling up its animal health diagnostics business, said Canaccord, which noted that it thinks Zoetis could make a bid for IDEXX. Canaccord reiterated its Buy rating and $80 price target on IDEXX shares, citing its cash on the balance sheet, low interest rates, recent CEO stock purchases and new product cycles that skew the risk/reward to the upside.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use